Autoimmune disease treatments

Autoimmune disease treatment is a topic in the health domain with significant developments in policy, regulation, and public health impact.

Key developments include novartis licenses mrna autoimmune therapy from abogen for up to $7.8 billion, bristol myers squibb halts autoimmune drug trials after deaths and life-threatening side effects, immunovant halts imvt-1402 cutaneous lupus program after phase 2 trial failure, among other significant events and policy changes.

Source: Geo Health Space